argenx SE (NAS:ARGX)
$ 376.96 20.95 (5.88%) Market Cap: 22.47 Bil Enterprise Value: 18.06 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 74/100

argenx SE at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2020 / 12:00PM GMT
Release Date Price: $229.04 (+0.21%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Great. Well good morning, everyone. Thanks to everyone for joining us this morning. My name is Graig Suvannavejh, and I am a U.S. and European biopharma analyst at Goldman Sachs. With me today are Tim Hauwermeiren -- Van Hauwermeiren. Sorry if I butchered your name, Tim. Everyone butchers my name, so my apologies for that -- CEO of the company; and Keith Woods, who is Chief Operating Officer of the company. And so today, we're going to have a discussion on argenx. And with that said, obviously, we want to lead maybe straight off with talking with Tim, just about the successes that argenx has had. Tim cofounded the company back in 2008. We're now in 2020.

Questions & Answers

Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

So maybe if we could just start with maybe a high-level brief perspective of kind of the vision you saw for argenx 12 years ago. And maybe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot